Literature DB >> 9604284

The three-dimensional structures of two toxins from snake venom throw light on the anticoagulant and neurotoxic sites of phospholipase A2.

E Carredano1, B Westerlund, B Persson, M Saarinen, S Ramaswamy, D Eaker, H Eklund.   

Abstract

The three-dimensional structures of the class II anticoagulant phospholipase A2 (PLA2) toxin RVV-VD from the venom of Russell's viper, Vipera russelli russelli, and the class I neurotoxic PLA2 Notechis II-5 from the, Australian tiger snake, Notechis scutatus scutatus, were determined to 2.2 A and 3.0 A resolution, respectively. Both enzymes are monomeric and consist of 121 and 119 residues, respectively. A comparison of ten class I/II PLA2 structures showed, among other differences, that the beta-sheet of these enzymes (residues 76-83) is about 90 degrees less twisted in class I than in class II PLA2s. This, along with the insertion of some residues in the region 57-59 in class I enzymes (the elapid loop), could be the main reason for the significant difference in the anticoagulant and (presynaptic) neurotoxic properties between the two classes of PLA2. It seems apparent from sequence and structural comparisons that the toxic site of PLA2 responsible for the strong anticoagulancy of these toxins consists of a negatively charged part, Glu53, together with a positively charged ridge of lysine residues free for intermolecular interactions. These lysines differ between the two classes of PLA2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9604284     DOI: 10.1016/s0041-0101(97)00051-2

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  8 in total

1.  Purification and characterization of a potent hemolytic toxin with phospholipase A2 activity from the venom of Indian Russell's viper.

Authors:  Amit K Chakraborty; Robert H Hall; Asoke C Ghose
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

Review 2.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

Review 3.  Modifications of natural peptides for nanoparticle and drug design.

Authors:  Andrew P Jallouk; Rohun U Palekar; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Adv Protein Chem Struct Biol       Date:  2015-03-12       Impact factor: 3.507

4.  Crystallization and preliminary X-ray diffraction analysis of three myotoxic phospholipases A2 from Bothrops brazili venom.

Authors:  Carlos A H Fernandes; Elaine C G Gartuzo; Ivan Pagotto; Edson J Comparetti; Salomón Huancahuire-Vega; Luis Alberto Ponce-Soto; Tássia R Costa; Sergio Marangoni; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

5.  Rapid evolution by positive selection and gene gain and loss: PLA(2) venom genes in closely related Sistrurus rattlesnakes with divergent diets.

Authors:  H Lisle Gibbs; Wayne Rossiter
Journal:  J Mol Evol       Date:  2008-02-06       Impact factor: 3.973

6.  Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics.

Authors:  Grazyna Faure; Veerabasappa T Gowda; Rachid C Maroun
Journal:  BMC Struct Biol       Date:  2007-12-06

7.  Variability in venom composition of European viper subspecies limits the cross-effectiveness of antivenoms.

Authors:  Giulia Zanetti; Elisa Duregotti; Carlo Alessandro Locatelli; Andrea Giampreti; Davide Lonati; Ornella Rossetto; Marco Pirazzini
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

Review 8.  Cytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l-amino acid oxidase.

Authors:  Jia Jin Hiu; Michelle Khai Khun Yap
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.